218 related articles for article (PubMed ID: 21943092)
1. A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells.
Castiel A; Visochek L; Mittelman L; Dantzer F; Izraeli S; Cohen-Armon M
BMC Cancer; 2011 Sep; 11():412. PubMed ID: 21943092
[TBL] [Abstract][Full Text] [Related]
2. Cell death associated with abnormal mitosis observed by confocal imaging in live cancer cells.
Castiel A; Visochek L; Mittelman L; Zilberstein Y; Dantzer F; Izraeli S; Cohen-Armon M
J Vis Exp; 2013 Aug; (78):e50568. PubMed ID: 23995751
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel small molecule inhibitors of centrosome clustering in cancer cells.
Kawamura E; Fielding AB; Kannan N; Balgi A; Eaves CJ; Roberge M; Dedhar S
Oncotarget; 2013 Oct; 4(10):1763-76. PubMed ID: 24091544
[TBL] [Abstract][Full Text] [Related]
4. Targeting TAO Kinases Using a New Inhibitor Compound Delays Mitosis and Induces Mitotic Cell Death in Centrosome Amplified Breast Cancer Cells.
Koo CY; Giacomini C; Reyes-Corral M; Olmos Y; Tavares IA; Marson CM; Linardopoulos S; Tutt AN; Morris JDH
Mol Cancer Ther; 2017 Nov; 16(11):2410-2421. PubMed ID: 28830982
[TBL] [Abstract][Full Text] [Related]
5. Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction.
Kalkan BM; Ozcan SC; Cicek E; Gonen M; Acilan C
Cell Death Dis; 2024 Mar; 15(3):222. PubMed ID: 38493150
[TBL] [Abstract][Full Text] [Related]
6. Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen.
Rebacz B; Larsen TO; Clausen MH; Rønnest MH; Löffler H; Ho AD; Krämer A
Cancer Res; 2007 Jul; 67(13):6342-50. PubMed ID: 17616693
[TBL] [Abstract][Full Text] [Related]
7. Aurora A inhibition limits centrosome clustering and promotes mitotic catastrophe in cells with supernumerary centrosomes.
Navarro-Serer B; Childers EP; Hermance NM; Mercadante D; Manning AL
Oncotarget; 2019 Feb; 10(17):1649-1659. PubMed ID: 30899434
[TBL] [Abstract][Full Text] [Related]
8. Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death.
Ogden A; Cheng A; Rida PC; Pannu V; Osan R; Clewley R; Aneja R
Cell Death Dis; 2014 May; 5(5):e1204. PubMed ID: 24787016
[TBL] [Abstract][Full Text] [Related]
9. Centrosome Clustering Is a Tumor-selective Target for the Improvement of Radiotherapy in Breast Cancer Cells.
Choe MH; Kim J; Ahn J; Hwang SG; Oh JS; Kim JS
Anticancer Res; 2018 Jun; 38(6):3393-3400. PubMed ID: 29848688
[TBL] [Abstract][Full Text] [Related]
10. Using Cell Culture Models of Centrosome Amplification to Study Centrosome Clustering in Cancer.
Kwon M
Methods Mol Biol; 2016; 1413():367-92. PubMed ID: 27193861
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of mitotic interaction between the nucleoporin Tpr and aurora kinase A.
Kobayashi A; Hashizume C; Dowaki T; Wong RW
Cell Cycle; 2015; 14(9):1447-58. PubMed ID: 25789545
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of an allosteric inhibitor of HSET that targets cancer cells with supernumerary centrosomes.
Watts CA; Richards FM; Bender A; Bond PJ; Korb O; Kern O; Riddick M; Owen P; Myers RM; Raff J; Gergely F; Jodrell DI; Ley SV
Chem Biol; 2013 Nov; 20(11):1399-410. PubMed ID: 24210220
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
14. Centrosomes and cancer: how cancer cells divide with too many centrosomes.
Godinho SA; Kwon M; Pellman D
Cancer Metastasis Rev; 2009 Jun; 28(1-2):85-98. PubMed ID: 19156503
[TBL] [Abstract][Full Text] [Related]
15. A mechanism linking extra centrosomes to chromosomal instability.
Ganem NJ; Godinho SA; Pellman D
Nature; 2009 Jul; 460(7252):278-82. PubMed ID: 19506557
[TBL] [Abstract][Full Text] [Related]
16. Centrosome Clustering & Chemotherapy.
Firdous F; Raza HG; Chotana GA; Choudhary MI; Faisal A; Saleem RSZ
Mini Rev Med Chem; 2023; 23(4):429-451. PubMed ID: 35993466
[TBL] [Abstract][Full Text] [Related]
17. Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents.
Dowling M; Voong KR; Kim M; Keutmann MK; Harris E; Kao GD
Cancer Biol Ther; 2005 Feb; 4(2):197-206. PubMed ID: 15753652
[TBL] [Abstract][Full Text] [Related]
18. A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment.
Wakefield JG; Stephens DJ; Tavaré JM
J Cell Sci; 2003 Feb; 116(Pt 4):637-46. PubMed ID: 12538764
[TBL] [Abstract][Full Text] [Related]
19. Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering.
Johannes JW; Almeida L; Daly K; Ferguson AD; Grosskurth SE; Guan H; Howard T; Ioannidis S; Kazmirski S; Lamb ML; Larsen NA; Lyne PD; Mikule K; Ogoe C; Peng B; Petteruti P; Read JA; Su N; Sylvester M; Throner S; Wang W; Wang X; Wu J; Ye Q; Yu Y; Zheng X; Scott DA
Bioorg Med Chem Lett; 2015 Dec; 25(24):5743-7. PubMed ID: 26546219
[TBL] [Abstract][Full Text] [Related]
20. Centrosomal clustering contributes to chromosomal instability and cancer.
Milunović-Jevtić A; Mooney P; Sulerud T; Bisht J; Gatlin JC
Curr Opin Biotechnol; 2016 Aug; 40():113-118. PubMed ID: 27046071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
